Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review

RATIONALE: Management of anxiety, delirium, and agitation cannot be neglected in coronavirus disease (COVID-19). Antipsychotics are usually used for the pharmacological management of delirium, and confusion and behavioral disturbances. The concurrent use of treatments for COVID-19 and antipsychotics...

Descripción completa

Detalles Bibliográficos
Autores principales: Plasencia-García, Beatriz Oda, Rodríguez-Menéndez, Gonzalo, Rico-Rangel, María Isabel, Rubio-García, Ana, Torelló-Iserte, Jaime, Crespo-Facorro, Benedicto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788177/
https://www.ncbi.nlm.nih.gov/pubmed/33410987
http://dx.doi.org/10.1007/s00213-020-05716-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788177/
https://www.ncbi.nlm.nih.gov/pubmed/33410987
http://dx.doi.org/10.1007/s00213-020-05716-4

Ejemplares similares